throbber
1/24/2017
`
`[Plasma- and tissue concentrations following intramuscular administration of etofenamat.... - Abstract - Europe PMC
`
`W Europe
`
`About
`
`Tools
`
`Developers
`
`Help
`
`Europe PMC plus
`
`8 Sign in or create an account
`
`Search worldwide, life-sciences literature
`
`E.g. "breast cancer" HER2 Smith J
`
`&. E W
`'
`A ‘
`G) R
`[3 Plasma- and tissue concentrations following intramusguelrgr (.at'dnr}riinist)r‘aOtriton
`etofenamat. Pharmacokinetics of etofenamat and flufenamic acid in plasma,
`
`synovium, and tissues of patients with chronic polyarthritis after administration of
`
`an oily solution of etofenamat
`
`(PM|D:1288513)
`
`Kdhler G , Tressel W, Dell HD , Doersing M , Fischer W , Kamp R , Langer M , Richter B , Wirzbach E
`
`Zentrum fur orthopadische Rheumatologie, Augsburg.
`
`Arzneimittel-Forschung [1992, 42(12):1487-1491]
`
`Type: Journal Article, English Abstract (lang: ger)
`
`Abstract
`
`Studies on Plasma and Tissue Concentrations of Etofenamate following Intramuscular
`
`Application/Pharmacokinetics of etofenamate and flutenamic acid in plasma, synovia and tissues of patients
`
`with chronic polyarthritis after application of oily etofenamat solution Pharmacokinetics of etofenamate (ETO,
`
`CAS 30544-47-9; Rheumon i.m.) and flufenamic acid (FLU, CAS 530-78-9) were investigated in plasma, synovial
`
`fluid, and tissues after single intramuscular application of etofenamate to patients with rheumatoid arthritis.
`
`62 patients with indicated operative procedure in the knee-joint received a single dose of etofenamate
`
`dissolved in oil before operation. At definite times between 1.5 and 48 h post injectionem samples from 6
`
`patients of each time group were collected. Samples of plasma, synovial fluid, synovial membrane, muscle,
`
`bone, hyaline cartilage, and fat tissue and in some cases meniscus cartilage were taken. Concentrations of ETO
`
`and its active metabolite, FLU, were determined by HPTLC. In all tissues investigated, concentration/time
`courses of ETO and FLU were observed. ETO and FLU were measured first in all matrices 1.5 h at the latest 3 h
`
`post injectionem. Pharmacokinetics in tissues follows that in plasma. Rate-limiting step is the liberation of drug
`
`from the oil depot. For a long period pharmacokinetics of ETO and FLU is mainly determined by the constant
`
`liberation from the oil depot (zero order kinetics of liberation). Zero order kinetics is deduced from the linear
`
`ascent of the cumulated AUC (in percent) vs. time plot. It is directly related to the liberation of drug from the
`
`galenical formu|ation.(ABSTRACT TRUNCATED AT 250 WORDS)
`
`http://europepmc.org/abstract/med/1288513
`
`94 Feedback
`
`1/2
`
`|nnoPharma Exhibit 1076.0001
`
`

`

`1/24/2017
`
`[Plasma- and tissue concentrations following intramuscular administration of etofenamat.... - Abstract - Europe PMC
`
`Formats
`
`Abstract
`
`Show annotations in this abstract
`
`L,J Chemicals
`
`IJ Diseases
`
`Q Gene Ontology
`
`Q Genes/Proteins
`
`About
`
`Tools
`
`Developers
`
`Help
`
`Contact us
`
`About Europe PMC
`
`Tools overview
`
`Developer resources
`
`Help using Europe PMC
`
`Helpdesk
`
`Funders
`
`ORCID article claiming
`
`Articles RESTfu| API
`
`Contact us
`
`Joining Europe PMC
`
`Journal list
`
`Grants RESTfu| API
`
`Governance
`
`Roadmap
`
`Grant finder
`
`SOAP web service
`
`External links service
`RSS feeds
`
`OAI service
`Bulk downloads
`
`SciLite annotations
`
`Feedback
`
`Twitter
`
`Blog
`
`
`Europe PMC is a service of the Euro e PMC Funders’ Grou
`
`in partnership with the European Bioinformatics Institute‘, and in
`
`cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine (NCBI/NLM}. It includes
`
`content provided to the PMC International archive by participating publishers.
`
`B ‘I3
`
`9' 9
`
`Contact Us | Terms of Use | Copyright | Accessibility | Cookies
`
`http://europepmc.org/abstract/med/1288513
`
`2/2
`
`|nnoPharma Exhibit 1076.0002
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket